SREBP-2, a new target of metformin?
Fengxia Zhang,1,* Wenxiu Sun,2,* Jianbo Chen,3 Lusheng Jiang,3 Ping Yang,3 Yufang Huang,3 Aihua Gong,3 Shudong Liu,3 Shizhan Ma4 1Department of Neurology, Affiliated Hospital of Shandong Traditional Chinese Medicine University, Jinan 250011, China; 2Department of Pharmacy, Taishan Vocational Colleg...
Main Authors: | Zhang F, Sun W, Chen J, Jiang L, Yang P, Huang Y, Gong A, Liu S, Ma S |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-12-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/srebp-2-a-new-target-of-metformin-peer-reviewed-article-DDDT |
Similar Items
-
SREBP-2-deficient and hypomorphic mice reveal roles for SREBP-2 in embryonic development and SREBP-1c expression[S]
by: Laurent Vergnes, et al.
Published: (2016-03-01) -
Therapeutic Applications of Type 2 Diabetes Mellitus Drug Metformin in Patients with Osteoarthritis
by: Parkyong Song, et al.
Published: (2021-02-01) -
Identification of twenty-three mutations in fission yeast Scap that constitutively activate SREBP*
by: Adam L. Hughes, et al.
Published: (2008-09-01) -
Aerobic Exercise Facilitates the Nuclear Translocation of SREBP2 by Activating AKT/SEC24D to Contribute Cholesterol Homeostasis for Improving Cognition in APP/PS1 Mice
by: Zelin Hu, et al.
Published: (2023-08-01) -
Estrogen stimulates SREBP2 expression in hepatic cell lines via an estrogen response element in the SREBP2 promoter
by: Ye Meng, et al.
Published: (2019-12-01)